Machine Learning Efficiency in Predicting Obstructive Coronary Artery Disease in Patients with Non-ST Elevation Acute

M M Tsivanyuk1, K I Shakhgeldyan2, M A Markov3

  • 1Senior Researcher, Laboratory of Big Data Analysis in Healthcare and Medicine; Far East Federal University, 10 Ayaks Village, Russkiy Island, Vladivostok, 690922, Russia; Interventional Cardiologist; Vladivostok City Clinical Hospital No.1, 22 Sadovaya St., Vladivostok, 690078, Russia.

Insights

Accurate prognostic models for obstructive coronary artery disease (OCAD) were developed for non-ST segment elevation acute coronary syndrome (NSTE-ACS) patients. Machine learning, particularly SGB, identified key predictors for early risk stratification and guiding treatment strategies.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Predictive Analytics

Background:

  • Non-ST segment elevation acute coronary syndrome (NSTE-ACS) requires accurate risk stratification for obstructive coronary artery disease (OCAD).
  • Early assessment of OCAD can significantly impact treatment decisions and patient outcomes.

Purpose of the Study:

  • To evaluate the accuracy of machine learning-based prognostic models for OCAD in NSTE-ACS patients within the initial hours of hospital admission.
  • To identify key clinical, demographic, and physiological predictors of OCAD in this patient cohort.

Main Methods:

  • Developed and compared multifactorial logistic regression, random forest, and stochastic gradient boosting (SGB) models.
  • Utilized 62 parameters including clinical, anthropometric, laboratory, ECG, and echocardiographic data.
  • Assessed model performance using six metrics and predictor importance via SHAP values across three time-scenarios (admission, 1-hour, 3-hour).

Main Results:

  • SGB models demonstrated superior performance across all three prognostic scenarios (AUCs: 0.846, 0.887, 0.949).
  • Key predictors included anthropometric measures (waist circumference, hip circumference, ratio) early on, and global longitudinal systolic strain later.
  • Risk stratification categories (low, medium, high, very high) were established based on SGB model outputs.

Conclusions:

  • Prognostic OCAD models based on SGB offer high accuracy for assessing coronary damage in early NSTE-ACS hospitalization.
  • The third-scenario model, incorporating diverse data including echocardiography, achieved the highest predictive accuracy.
  • These models serve as valuable tools for OCAD risk stratification and optimizing myocardial revascularization strategies.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
25
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
80
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
47
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
37
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
123